Recombinant Human LILRA5

Product Specifications

Product Name Alternative

Leukocyte immunoglobulin-like receptor subfamily A member 5, CD85 antigen-like family member F, Immunoglobulin-like transcript 11, ILT-11, Leukocyte immunoglobulin-like receptor 9, LIR-9, CD85f, LILRA5, LILRB7

UniProt

A6NI73

Expression Region

42-268

Host

Mammalian Cells

Tag

C-terminal His Tag

Applications

Western Blot, ELISA

Field of Research

Immunology, Signal Transduction

Endotoxin

< 1 EU/µg as determined by LAL test.

Purity

Greater than 95% as determined by SDS-PAGE.

Form

Lyophilized powder

Reconstitution

Centrifuge the vial at 10000 rpm for 30 s before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/ml by gently pipetting 2-3 times, don't vortex.

Molecular Weight

35-40 kDa

Shipping Conditions

4°C with ice bag

Storage Conditions

The lyophilized protein is stable at -20 °C for up to 1 year. For extended storage, it is recommended to further dilute in working aliquots after reconstitution. The protein solution is stable at ≤ -20 °C for 3 months, or 2-7 days at 2-8 °C under sterile conditions.Avoid repeated freeze/thaw cycle.